Trials / Withdrawn
WithdrawnNCT02606110
Pilot Study Investigating the Use of the ReBuilder to Treat Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Eastern Regional Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The purpose of this study is to investigate the effect of the ReBuilder in the treatment of individuals with breast cancer and chemotherapy induced peripheral neuropathy.
Conditions
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2015-12-01
- First posted
- 2015-11-17
- Last updated
- 2017-07-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02606110. Inclusion in this directory is not an endorsement.